MMIRF
Price
$0.02
Change
-$0.05 (-71.43%)
Updated
Apr 9 closing price
Capitalization
45.51M
NWPHF
Price
$9.36
Change
-$2.64 (-22.00%)
Updated
Sep 9 closing price
Capitalization
171.45M
Ad is loading...

MMIRF vs NWPHF

Header iconMMIRF vs NWPHF Comparison
Open Charts MMIRF vs NWPHFBanner chart's image
Medmira
Price$0.02
Change-$0.05 (-71.43%)
Volume$1K
Capitalization45.51M
Newron Pharmaceuticals SPA
Price$9.36
Change-$2.64 (-22.00%)
Volume$500
Capitalization171.45M
MMIRF vs NWPHF Comparison Chart
Loading...
View a ticker or compare two or three
VS
MMIRF vs. NWPHF commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMIRF is a Hold and NWPHF is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (MMIRF: $0.02 vs. NWPHF: $9.36)
Brand notoriety: MMIRF and NWPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MMIRF: 17% vs. NWPHF: 100%
Market capitalization -- MMIRF: $45.51M vs. NWPHF: $171.45M
MMIRF [@Biotechnology] is valued at $45.51M. NWPHF’s [@Biotechnology] market capitalization is $171.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MMIRF’s FA Score shows that 0 FA rating(s) are green whileNWPHF’s FA Score has 0 green FA rating(s).

  • MMIRF’s FA Score: 0 green, 5 red.
  • NWPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, both MMIRF and NWPHF are a bad buy in the long-term.

Price Growth

MMIRF (@Biotechnology) experienced а 0.00% price change this week, while NWPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

MMIRF is expected to report earnings on Apr 02, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
NWPHF($171M) has a higher market cap than MMIRF($45.5M). MMIRF YTD gains are higher at: 58.015 vs. NWPHF (0.000).
MMIRFNWPHFMMIRF / NWPHF
Capitalization45.5M171M27%
EBITDA-3.13MN/A-
Gain YTD58.0150.000-
P/E RatioN/AN/A-
Revenue277KN/A-
Total Cash296KN/A-
Total Debt9.49MN/A-
FUNDAMENTALS RATINGS
MMIRF vs NWPHF: Fundamental Ratings
MMIRF
NWPHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
9773
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6351
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (50) in the null industry is in the same range as NWPHF (50). This means that MMIRF’s stock grew similarly to NWPHF’s over the last 12 months.

NWPHF's Profit vs Risk Rating (73) in the null industry is in the same range as MMIRF (97). This means that NWPHF’s stock grew similarly to MMIRF’s over the last 12 months.

NWPHF's SMR Rating (99) in the null industry is in the same range as MMIRF (100). This means that NWPHF’s stock grew similarly to MMIRF’s over the last 12 months.

NWPHF's Price Growth Rating (51) in the null industry is in the same range as MMIRF (63). This means that NWPHF’s stock grew similarly to MMIRF’s over the last 12 months.

NWPHF's P/E Growth Rating (100) in the null industry is in the same range as MMIRF (100). This means that NWPHF’s stock grew similarly to MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
API3.200.06
+1.91%
Agora
TSCO49.920.92
+1.88%
Tractor Supply Co
HWC52.01-0.29
-0.55%
Hancock Whitney Corp
CRON1.80-0.05
-2.70%
Cronos Group
RLMD0.65-0.09
-12.51%
Relmada Therapeutics

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
-5.76%
AZTR - MMIRF
24%
Poorly correlated
+3.86%
SRPT - MMIRF
22%
Poorly correlated
-2.14%
SAGE - MMIRF
22%
Poorly correlated
N/A
More

NWPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NWPHF has been loosely correlated with NOXOF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NWPHF jumps, then NOXOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NWPHF
1D Price
Change %
NWPHF100%
N/A
NOXOF - NWPHF
54%
Loosely correlated
N/A
MMIRF - NWPHF
30%
Poorly correlated
N/A
ACET - NWPHF
27%
Poorly correlated
-4.62%
IGXT - NWPHF
23%
Poorly correlated
N/A
NTRB - NWPHF
19%
Poorly correlated
N/A
More